OriC902

· Peking University

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for OriC902, covering 2025-03-24 to 2025-03-24. Get the full timeline:

Most recent: Clinical Trial Update: Phase I Study of OriC902 in Treatment of Advanced HCC [Phase 1]